Search results
The Zacks Analyst Blog Highlights BBC, CNCR XBI, BBP, and SBIO
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – July 11, 2022 – Zacks.com announces the list of stocks featured...
Calculating The Fair Value Of Hor Kew Corporation Limited (SGX:BBP)
Simply Wall St. via Yahoo Finance· 12 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Hor Kew fair value estimate is S$0.25 Hor...
Hor Kew (SGX:BBP) Is Experiencing Growth In Returns On Capital
Simply Wall St. via Yahoo Finance· 11 months agoTo find a multi-bagger stock, what are the underlying trends we should look for in a business?...
Hor Kew (SGX:BBP) Is Doing The Right Things To Multiply Its Share Price
Simply Wall St. via Yahoo Finance· 6 months agoIf we want to find a stock that could multiply over the long term, what are the underlying trends we...
BridgeBio (BBIO) Up on Deal With BMY for SHP2 Inhibitor
Zacks via Yahoo Finance· 2 years agoShares of BridgeBio Pharma, Inc. BBIO were up 14% on Thursday May 12, after management announced...
Hor Kew (SGX:BBP) Is Looking To Continue Growing Its Returns On Capital
Simply Wall St. via Yahoo Finance· 2 weeks agoWhat trends should we look for it we want to identify stocks that can multiply in value over the...
Hor Kew Corporation Limited's (SGX:BBP) Price Is Right But Growth Is Lacking
Simply Wall St. via Yahoo Finance· 1 year agoWhen close to half the companies in Singapore have price-to-earnings ratios (or "P/E's") above 11x,...
Biotech & Crypto -- Best ETF Areas of Last Week
Zacks via Yahoo Finance· 2 years agoWall Street was moderate last week. The S&P 500 (up 0.4%), the Dow Jones (down 0.13%), the Nasdaq (up 2.2%) and the Russell 2000 (up 1.94%) delivered a...
BridgeBio Pharma Posts Early Data From Neurological Movement Disorder Candidate
Benzinga via Yahoo Finance· 2 years agoBridgeBio Pharma Inc (NASDAQ: BBIO) has announced interim Phase 1 data from healthy volunteers,...
BridgeBio Starts Dosing In Early-Stage Genetic Metabolism Disorder Trial
Benzinga via Yahoo Finance· 2 years agoBridgeBio Pharma Inc (NASDAQ: BBIO) has dosed the first patient in its Phase 1 trial of BBP-671, an...
